5 completed, 4 recruiting, 4 unknown, 2 active not recruiting. 5 Phase 2, 4 Not applicable, 3 Phase 1, 2 Phase 3, 1 Early Phase 1.
Follow Renal Carcinoma: new trials by email Literature Review of Renal Carcinoma trials Research Report on Renal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC Casdatifan, Zimberelimab - Renal Cell Carcinoma, Kidney Cancer | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 32 | 2026-03-09 | 2026-03-20 |
| Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients Radiofrequency Ablation (RFA) - Renal Carcinoma | Not yet recruiting | Humanitas Hospital, Italy | 226 | 2026-03-01 | 2026-03-16 | |
| R.E.C.K vs Exparel in Robotic Nephrectomy Ropivacaine HCL, Exparel, Epinephrine - Renal Carcinoma, Nephrectomy / Methods | Phase 3 | Recruiting | Wake Forest University Health Sciences | 170 | 2025-11-14 | 2026-07-13 |
| Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy Augmented Reality Guided Biopsy, Ultrasound Guided Biopsy - Oncology, Interventional Radiology | Not applicable | Enrolling by invitation | MediView XR, Inc. | 104 | 2025-06-27 | 2025-07-02 |
| Symptomatic and Incidental RCC Detection Surgical treatment of renal lesions - Renal Cell Carcinoma (Kidney Cancer), Benign Renal Neoplasm | Completed | Charles University, Czech Republic | 1000 | 2025-06-01 | 2026-03-19 | |
| Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study Renal Carcinoma, Serology | Active not recruiting | First Affiliated Hospital of Fujian Medical University | 400 | 2025-04-01 | 2025-09-18 | |
| Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma Cytokine Induced Memory-like Natural Killer (CIML NK) Cells, Interleukin-2 (IL-2) - Renal Carcinoma, Renal Cell Carcinoma | Early Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 5 | 2024-08-28 | 2026-05-11 |
| Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K) DaVinci RAPN, Hugo RAS RAPN - Renal Carcinoma | Not applicable | Recruiting | Azienda Ospedaliera Universitaria Integrata Verona | 30 | 2024-02-01 | 2025-01-03 |
| Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR) Data collection - Renal Carcinoma | Unknown | Institut de cancérologie Strasbourg Europe | 600 | 2023-01-25 | 2022-11-25 | |
| A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors JS004, a recombinant humanized, IgG4κ monoclonal antibody (mAb) specific to B- and T-lymphocyte attenuator (BTLA); Toripalimab Injection - Melanoma, Renal Carcinoma | Phase 1 | Completed | Shanghai Junshi Bioscience Co., Ltd. | 47 | 2021-04-12 | 2026-07-08 |
| the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) - Bladder Cancer, Renal Carcinoma | Phase 2 | Completed | Dragonboat Biopharmaceutical Company Limited | 27 | 2020-09-11 | 2026-07-06 |
| Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations Olaparib - Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Phase 2 | Recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 | 2019-06-03 | 2026-03-30 |
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors Phase 1 : Regorafenib, Phase 1 : Avelumab, Phase 2 : Regorafenib - Colorectal Cancer Not MSI-H or MMR-deficient, GIST | Phase 1 / Phase 2 | Unknown | Institut Bergonié | 747 | 2018-05-04 | 2023-03-03 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies CAR-T cell immunotherapy - B-cell Acute Lymphoblastic Leukemia, Lymphoma | Phase 1 / Phase 2 | Unknown | Shenzhen BinDeBio Ltd. | 73 | 2018-03-01 | 2019-12-11 |
| Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery Robot-Assisted Laparoscopic Surgery, High-Intensity Focused Ultrasound Ablation, Therapeutic Laparoscopic Surgery - Renal Carcinoma, Renal Mass | Not applicable | Withdrawn | University of Southern California | 2017-12-18 | 2017-12-20 | |
| The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery Exercise Programme - Impaired Cognition, Quality of Life | Not applicable | Completed | University of Nottingham | 11 | 2017-06-26 | 2019-04-17 |
| Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium Minocycline, Placebo - Prostate Cancer, Carcinoma of the Rectum | Phase 3 | Unknown | RenJi Hospital | 750 | 2016-11-01 | 2020-01-28 |
| Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients To study the polymorphism of the gene encoding VEGF (rs699947) as a predictive marker - Polymorphism, VEGF | Completed | Centre Hospitalier Universitaire, Amiens | 272 | 2016-10-06 | 2026-06-24 |
Carcinoma, Renal Cell (18) · Carcinoma, Hepatocellular (3) · Carcinoma, Transitional Cell (3) · Kidney Neoplasms (3) · Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Melanoma (2) · Prostatic Neoplasms (2) · Stomach Neoplasms (2) · Urinary Bladder Neoplasms (2) · Agnosia (1) · Biliary Tract Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Cognition Disorders (1)
Adenocarcinoma (18) · Carcinoma (18) · Female Urogenital Diseases (18) · Female Urogenital Diseases and Pregnancy Complications (18) · Kidney Diseases (18) · Male Urogenital Diseases (18) · Neoplasms by Histologic Type (18) · Neoplasms by Site (18) · Neoplasms, Glandular and Epithelial (18) · Urogenital Diseases (18) · Urogenital Neoplasms (18) · Urologic Diseases (18) · Urologic Neoplasms (18) · Neoplasms (17) · Kidney Neoplasms (15)
BTLA protein, human (1) · Cell Count (1) · Clinical Trials, Phase II as Topic (1) · Clonidine (1) · Data Collection (1) · Epinephrine (1) · High-Intensity Focused Ultrasound Ablation (1) · Immunotherapy, Adoptive (1) · Interleukin-2 (1) · Ketorolac (1) · Minocycline (1) · Radiofrequency Ablation (1) · Ropivacaine (1) · olaparib (1) · regorafenib (1)
Dana-Farber Cancer Institute (2) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Centre Hospitalier Universitaire, Amiens (1) · Charles University, Czech Republic (1) · Dragonboat Biopharmaceutical Company Limited (1) · First Affiliated Hospital of Fujian Medical University (1) · Humanitas Hospital, Italy (1) · Institut Bergonié (1) · Institut de cancérologie Strasbourg Europe (1) · MediView XR, Inc. (1) · RenJi Hospital (1) · Shanghai Junshi Bioscience Co., Ltd. (1) · Shenzhen BinDeBio Ltd. (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of Nottingham (1)
United States (6) · China (5) · France (3) · Italy (2) · Czechia (1) · Spain (1) · United Kingdom (1)
Wenxin Xu, MD (2) · Alessandro AA Antonelli, MD (1) · Bethan Phillips, BSc PhD (1) · Dingwei Ye (1) · Jakub Hanych, MD (1) · John Williams, MBChB PhD (1) · Jon Lund, MD (1) · Jun Guo (1) · Laura Carrick, BSc MBChB (1) · Mark C Markowski, MD, Ph.D (1)
PMID 34965951, PMID 34998048, PMID 40204996, PMID 40579407
2016 (1), P30CA014089 (1)